Insilico Medicine
Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases
Overview
Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases. The job it does: building AI products and features, often for other companies.
Who is it for? Mostly companies adding AI to a product. Alongside the main category they mention Artificial Intelligence (AI), Biotechnology, Health Care and Pharmaceutical. They are a mid-sized team, 201 to 500 people, which usually shapes who they work with.
Insilico Medicine is based in Cambridge, Massachusetts and founded in 2014. More on insilico.com.
Our checklist for this category: track record, data handling, and who owns the models. Ask for a trial on your own data, not a canned demo.
If you have worked with Insilico Medicine, tell the next buyer what you paid and what surprised you. That is the part of this page we cannot write.
Key features
Biotechnology
Health Care
Pharmaceutical
Company
Write a review for Insilico Medicine
Talk to the vendor
Claim this product
Is this your product?
Claim it to reply to reviews, update your listing and see who is comparing you.
Claim this product